Since the introduction of modern inhalers, a significant proportion of the delivered medication has been deposited in the mouth and throat rather than reaching the lungs.

This may result in:

• Variable treatment efficacy

• Unnecessary drug waste

• Local side effects

• Increased environmental impact

ExactHaler® has been developed as a simple, passive add-on device without electronics or moving parts.

The technology:

• Can be used with existing inhalers

• Controls and encapsulates aerosol transport through the oral cavity

• Reduces unwanted deposition of medicine the mouth and throat

• Has great potential for increasing lung deposition

• Can reduce the required medication dose

ExactHaler® is being developed with the ambition to achieve:

• Reduced drug waste

• Potential dose reduction

• Lower propellant consumption

• Reduced carbon footprint from inhalation therapy

This supports both improved patient care and future sustainability goals within respiratory medicine.